 | Up a level |
Giriens, B; Yan, P; Safroneeva, E; Zwahlen, M; Reinhard, A; Nydegger, A; Vavricka, S; Sempoux, C; Straumann, A; Schoepfer, A M (2015). Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993-2013: a population-based study. Allergy, 70(12), pp. 1633-1639. Wiley-Blackwell 10.1111/all.12733
Safroneeva, E; Coslovsky, Michael; Kuehni, C E; Zwahlen, M; Haas, N. A.; Panczak, R; Taft, T H; Hirano, I; Dellon, E S; Gonsalves, N; Leung, J; Bussmann, C; Woosley, J T; Yan, P; Romero, Y; Furuta, G T; Gupta, S K; Aceves, S S; Chehade, M; Straumann, A; ... (2015). Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity. Alimentary pharmacology & therapeutics, 42(8), pp. 1000-1010. Wiley-Blackwell 10.1111/apt.13370
Moawad, F J; Schoepfer, A M; Safroneeva, E; Ally, M R; Chen, Y-J; Maydonovitch, C L; Wong, R K H (2014). Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings. Alimentary pharmacology & therapeutics, 39(6), pp. 603-608. Wiley-Blackwell 10.1111/apt.12636
Straumann, A; Safroneeva, E (2012). Eosinophils in the gastrointestinal tract: friends or foes? Acta gastro-enterologica belgica, 75(3), pp. 310-5. Brussels: Acta medica belgica
Meyrat, P; Safroneeva, E; Schoepfer, A M (2012). Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months. Alimentary pharmacology & therapeutics, 36(11-12), pp. 1084-93. Oxford: Wiley-Blackwell 10.1111/apt.12087
Wildi, S M; Schoepfer, A M; Vavricka, S R; Fruehauf, H; Safroneeva, E; Wiegand, N; Bauerfeind, P; Fried, M (2012). Colorectal polypectomy during insertion and withdrawal or only during withdrawal? A randomized controlled trial. Endoscopy, 44(11), pp. 1019-23. Stuttgart: Thieme 10.1055/s-0032-1310237
